AzTrials
AzTrials

Diet, HealthyNCT06435130

The Impact of Chokeberry Bioproducts on Metabolic Parameters and Antioxidant Potential

A study testing Dietary intervention with chokeberry juices and Dietary intervention with chokeberry juices and fibers in people with Diet, Healthy and Diabetes Mellitus, run by Medical University of Bialystok at 1 site in Poland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Chokeberry can be used both in the prevention and treatment of various metabolic disorders due to its high antioxidant properties. The study assessed for the first time the synergistic effect of chokeberry juice and chokeberry fiber on selected metabolic and anthropometric parameters. Read more about this study

Who is it for?
Ages 30 to 65 years
Conditions the study is for
Diet, Healthy, Diabetes Mellitus, Hypertension
What is being tested?
Dietary intervention with chokeberry juices and Dietary intervention with chokeberry juices and fibers
Could I receive a placebo?
No, everyone receives an active treatment
How many people
102 participants
Where
1 sitePoland
Study dates
1 May 2022to 30 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age 30-65 years,
  • low or moderate physical activity.

Who cannot join

  • age <30 and >65 years,
  • high physical activity,
  • obesity (class II),
  • diabetes (all types),
  • gastric ulcer,
  • acute or chronic gastritis,
Show all 11Show fewer
  • intestinal diseases, including inflammatory bowel diseases and functional intestinal disorders,
  • taking hypoglycemic, lipid-lowering, immunosuppressive, anticoagulant and antihypertensive drugs, use of steroid therapy,
  • high physical activity,
  • pregnancy,
  • breastfeeding.

Trial locations and contacts

1 site in 1 country.

Poland1 site
  • Medical University of Bialystok

    Bialystok, 15-089

Other trials in Poland

About this study

Official title: The Impact of Chokeberry Bioproducts Consumption on Metabolic Parameters and the Antioxidant Potential of Serum

Chokeberry can be used both in the prevention and treatment of various metabolic disorders due to its high antioxidant properties. The study assessed for the first time the synergistic effect of chokeberry juice and chokeberry fiber on selected metabolic and anthropometric parameters. 102 people (67 women and 35 men) took part in the intervention study. After 8 weeks of intervention with chokeberry juice and another 4 weeks of intervention with chokeberry juice and fiber, a change in waist circumference, blood pressure, glucose, glycated hemoglobin, LDL cholesterol, aspartate transaminase (AST) and the level of antioxidant potential was observed.

Being tested
Dietary intervention with chokeberry juices, Dietary intervention with chokeberry juices and fibers
Keywords
chokeberry, juice, fiber, diet, intervention, diabetes, obesity, hypertension, hypercholesterolemia
Medical subject headings
Diabetes Mellitus, Hypertension, Obesity, Hypercholesterolemia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dietary intervention with chokeberry juicesOther

    The first stage of the dietary intervention lasted 8 weeks. Study participants consumed 100 ml of chokeberry juice daily. Chokeberry juice came from ecological cultivation (Poland). Participants qualified for the study had specific biochemical parameters tested: fasting glucose and insulin level, lipid profile (triglycerides, total cholesterol, LDL-cholesterol, HDL-cholesterol), glycated hemoglobin, uric acid, C-reactive protein (CRP), creatinine, liver enzymes: alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamylotranspeptydase (GGTP), homocysteine and antioxidant potential. Blood tests were performed in a certified external laboratory before and after 8 weeks of intervention. In addition, blood pressure and waist circumference were tested.

  • Dietary intervention with chokeberry juices and fibersOther

    The second stage of the dietary intervention lasted 4 weeks. Study participants consumed 100 ml of chokeberry juice daily and 10 g chokeberry fiber daily (from ecological cultivation, Poland). Blood tests were performed in a certified external laboratory after 4 weeks of intervention. The following blood tests were performed: fasting glucose and insulin level, lipid profile (triglycerides, total cholesterol, LDL-cholesterol, HDL-cholesterol), glycated hemoglobin, uric acid, C-reactive protein (CRP), creatinine, liver enzymes: alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamylotranspeptydase (GGTP), homocysteine and antioxidant potential. In addition, blood pressure and waist circumference were tested.

Study groups in NCT06435130
Study groupRoleWhat they receive
Dietary intervention with chokeberry juice and fibreExperimentalStudy participants consumed 100 mL of chokeberry juice daily for 8 weeks. After 8 weeks, participants consumed 100 ml of chokeberry juice and 10 g of chokeberry fiber daily for 4 weeks.
Receives: Other: Dietary intervention with chokeberry juices; Other: Dietary intervention with chokeberry juices and fibers

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in waist circumference

    After 8 weeks of using chokeberry juice-100 mL daily and another 4 weeks of using chokeberry juice - 100 mL daily and chokeberry fiber - 10 g daily, a change in waist circumference was observed.

    Measured: 12 weeks

  2. Change in blood pressure

    After 8 weeks of using chokeberry juice-100 mL daily and another 4 weeks of using chokeberry juice - 100 mL daily and chokeberry fiber - 10 g daily, a change in systolic and diastolic blood pressure was observed.

    Measured: 12 weeks

  3. Change in glycated hemoglobin

    After 8 weeks of using chokeberry juice-100 mL daily and another 4 weeks of using chokeberry juice - 100 mL daily and chokeberry fiber - 10 g daily, a change in glycated hemoglobin was observed.

    Measured: 12 weeks

  4. Change in glucose level

    After 8 weeks of using chokeberry juice-100 mL daily and another 4 weeks of using chokeberry juice - 100 mL daily and chokeberry fiber - 10 g daily, a change in glucose level was observed.

    Measured: 12 weeks

  5. Change in LDL-cholesterol

    After 8 weeks of using chokeberry juice-100 mL daily and another 4 weeks of using chokeberry juice - 100 mL daily and chokeberry fiber - 10 g daily, a change in LDL-cholesterol level was observed.

    Measured: 12 weeks

  6. Change in aspartate transaminase (AST) level

    After 8 weeks of using chokeberry juice-100 mL daily and another 4 weeks of using chokeberry juice - 100 mL daily and chokeberry fiber - 10 g daily, a change in aspartate transaminase (AST) level was observed.

    Measured: 12 weeks

  7. Change in antioxidant potential of serum

    After 8 weeks of using chokeberry juice-100 mL daily and another 4 weeks of using chokeberry juice - 100 mL daily and chokeberry fiber - 10 g daily, a change in antioxidant potential of serum was observed.

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 May 2024
  2. Study start1 May 2022
  3. Primary completion30 Aug 2022
  4. Study completion30 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Model description
102 people (67 women and 35 men) with metabolic disorders were included in the interventional study
Masking
None (open label)
Enrolment
102 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06435130
Sponsor's protocol ID
MUBialystok2
Status last verified
May 2024
First submitted
20 May 2024
Last updated
30 May 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Zujko ME, Rozniata M, Zebrowska-Gamdzyk M. Effects of Chokeberry Juice Added to a Mediterranean-Style Diet on Glycemic Control and Redox Homeostasis in Women with Prediabetes: A Randomized Controlled Trial. Nutrients. 2026 Sep 9;18(18):2948. doi: 10.3390/nu18182948.

    PubMed 42796931

Questions about this trial

What is this clinical trial studying?

A study testing Dietary intervention with chokeberry juices and Dietary intervention with chokeberry juices and fibers in people with Diet, Healthy and Diabetes Mellitus, run by Medical University of Bialystok at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in waist circumference (time frame: 12 weeks). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06435130, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in